These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9875271)

  • 1. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.
    Eikelenboom P; Rozemuller JM; van Muiswinkel FL
    Exp Neurol; 1998 Nov; 154(1):89-98. PubMed ID: 9875271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
    Bamberger ME; Landreth GE
    Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity, local inflammation, and degenerative disease.
    McGeer PL; McGeer EG
    Sci Aging Knowledge Environ; 2002 Jul; 2002(29):re3. PubMed ID: 14602998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation as a pathogenic mechanism in Alzheimer's disease.
    Rogers J
    Arzneimittelforschung; 1995 Mar; 45(3A):439-42. PubMed ID: 7763341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
    Koistinaho M; Koistinaho J
    Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
    Lue LF; Walker DG
    J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia as a potential bridge between the amyloid beta-peptide and tau.
    Kitazawa M; Yamasaki TR; LaFerla FM
    Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of inflammation in Alzheimer's disease.
    Tuppo EE; Arias HR
    Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.
    McGeer EG; McGeer PL
    Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide--the first step of a fatal cascade.
    Wirths O; Multhaup G; Bayer TA
    J Neurochem; 2004 Nov; 91(3):513-20. PubMed ID: 15485483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory processes in Alzheimer's disease.
    McGeer EG; McGeer PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):741-9. PubMed ID: 12921904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
    Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
    Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
    Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: a putative marker of an ongoing inflammatory process.
    McRae A; Martins RN; Fonte J; Kraftsik R; Hirt L; Miklossy J
    Exp Gerontol; 2007 Apr; 42(4):355-63. PubMed ID: 17140756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In search of a treatment for Alzheimer's disease and potential immunonosuppresive therapeutic interventions.
    Dhawan N; Puangco J; Jandial R
    Neuro Endocrinol Lett; 2008 Aug; 29(4):410-20. PubMed ID: 18766151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frame-shifted amyloid precursor protein found in Alzheimer's disease and Down's syndrome increases levels of secreted amyloid beta40.
    van Dijk R; Fischer DF; Sluijs JA; Sonnemans MA; Hobo B; Mercken L; Mann DM; Hol EM; van Leeuwen FW
    J Neurochem; 2004 Aug; 90(3):712-23. PubMed ID: 15255950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.